对高风险多发性髓瘤的治疗方法
Xiaoyi Chen1, Gaurav Varma1, Faith Davies1
1Center Blood Cancer, Perlmutter Cancer Center, New York University, NYCLangone, Room# 496, Medical Science Building 4th Floor, 540 1st Avenue, New York, NY 10016, USA.
Hematology/oncology clinics of North America
|January 9, 2024
概括
改善高风险骨髓瘤 (HRMM) 的结果需要了解其遗传驱动因素并针对其生物学. 虽然预后仍然具有挑战性,但实现疾病根除可能会导致治愈.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 高风险骨髓瘤 (HRMM) 具有重大治疗挑战,预后通常不佳.
- 目前的治疗策略,包括新型免疫疗法,有所改善,但可能无法克服HRMM固有的攻击性.
- 更深入地了解HRMM的遗传基础对于开发更有效的疗法至关重要.
研究的目的:
- 突出提高高风险髓瘤治疗结果的急需性.
- 强调阐明基因驱动因素对于有针对性的治疗开发的重要性.
- 通过在HRMM中实现最小残留疾病状态来探索治愈的潜力.
主要方法:
- 对高风险髓瘤的当前治疗策略和共识指南的审查.
- 分析遗传驱动因素在HRMM预后中的作用.
- 在HRMM的背景下对新型免疫治疗方法的评估.
主要成果:
- 尽管有进展,高风险骨髓瘤患者经常面临预后受损.
- 了解和准特定的遗传驱动因素对于治疗进步至关重要.
- 正在实施新的策略,重点关注共识指导和免疫治疗.
结论:
- 实现完整的疾病根除和最小的疾病状态为高风险骨髓瘤提供了治愈的潜力.
- 对遗传驱动因素和新型治疗点的持续研究至关重要.
- 未来十年的目标是通过生物向显著改善高风险骨髓瘤的结果.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332
